SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (5607)4/11/2004 5:03:26 PM
From: Harold Engstrom  Respond to of 10345
 
George, I think this is a very different case. Firstly, psoraiasis is not a pleasant disease, but it is also not life-threatening like MS. Secondly, the FDA did not guide Biogen to file early based on interim data like they apparently have done with Antegren. Thirdly, is Amevive an order of magnitude more effective than alternative treatments like Antegren appears to be? (answer is no.) All that won't eliminate risk, but the telltales seem to point to favorable winds.



To: aknahow who wrote (5607)4/12/2004 5:43:45 PM
From: Cacaito  Respond to of 10345
 
Please, stop beating that dunky, Biogen did a SUPERB job not only getting Amevive across the FDA with WAY MORE EASE than the xomaDna MESS (Pk, THREE EXTRA Phase III) (despite the conspiration and alleged corruption handling that was vomited by antiBiogen posters) and is doing better selling the drug up to now, ESPECIALLY that they came from BEHIND cRaptiva after the Antova program debacle. The European torpedo from Serono work its way against Amevive, in any case good luck for xoma if they ever made money (like $1 billion in sales) with their european advantage. Notice that sra is a reccomended short!!!

You are still on time to double your money WITH EASE with the SURE Antegren. It could not be easier, the science is clearcut, only the company finances to be figured out.

And the AZ program FOR FREE (if one believes in bpi, there are tons more evidence for the Amyloid theory).